Priority Activities in Child and Adolescent Tuberculosis to Close the Policy-Practice Gap in Low- and Middle-Income Countries
Over the past 15 years, and despite many difficulties, significant progress has been made to advance child and adolescent tuberculosis (TB) care. Despite increasing availability of safe and effective treatment and prevention options, TB remains a global health priority as a major cause of child and adolescent morbidity and mortality-over one and a half million children and adolescents develop TB each year. A history of the global public health perspective on child and adolescent TB is followed by 12 narratives detailing challenges and progress in 19 TB endemic low and middle-income countries. Overarching challenges include: under-detection and under-reporting of child and adolescent TB; poor implementation and reporting of contact investigation and TB preventive treatment services; the need for health systems strengthening to deliver effective, decentralized services; and lack of integration between TB programs and child health services. The COVID-19 pandemic has had a significant negative impact on case detection and treatment outcomes. Child and adolescent TB working groups can address country-specific challenges to close the policy-practice gaps by developing and supporting decentral ized models of care, strengthening clinical and laboratory diagnosis, including of multidrug-resistant TB, providing recommended options for treatment of disease and infection, and forging strong collaborations across relevant health sectors.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Pathogens (Basel, Switzerland) - 11(2022), 2 vom: 01. Feb. |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Adolescent |
|---|
| Anmerkungen: |
Date Revised 12.05.2022 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/pathogens11020196 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM337466491 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM337466491 | ||
| 003 | DE-627 | ||
| 005 | 20231225234454.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/pathogens11020196 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1124.xml |
| 035 | |a (DE-627)NLM337466491 | ||
| 035 | |a (NLM)35215139 | ||
| 035 | |a (PII)196 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a du Preez, Karen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Priority Activities in Child and Adolescent Tuberculosis to Close the Policy-Practice Gap in Low- and Middle-Income Countries |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 12.05.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Over the past 15 years, and despite many difficulties, significant progress has been made to advance child and adolescent tuberculosis (TB) care. Despite increasing availability of safe and effective treatment and prevention options, TB remains a global health priority as a major cause of child and adolescent morbidity and mortality-over one and a half million children and adolescents develop TB each year. A history of the global public health perspective on child and adolescent TB is followed by 12 narratives detailing challenges and progress in 19 TB endemic low and middle-income countries. Overarching challenges include: under-detection and under-reporting of child and adolescent TB; poor implementation and reporting of contact investigation and TB preventive treatment services; the need for health systems strengthening to deliver effective, decentralized services; and lack of integration between TB programs and child health services. The COVID-19 pandemic has had a significant negative impact on case detection and treatment outcomes. Child and adolescent TB working groups can address country-specific challenges to close the policy-practice gaps by developing and supporting decentral ized models of care, strengthening clinical and laboratory diagnosis, including of multidrug-resistant TB, providing recommended options for treatment of disease and infection, and forging strong collaborations across relevant health sectors | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a adolescent | |
| 650 | 4 | |a child | |
| 650 | 4 | |a national tuberculosis program | |
| 650 | 4 | |a tuberculosis | |
| 700 | 1 | |a Gabardo, Betina Mendez Alcântara |e verfasserin |4 aut | |
| 700 | 1 | |a Kabra, Sushil K |e verfasserin |4 aut | |
| 700 | 1 | |a Triasih, Rina |e verfasserin |4 aut | |
| 700 | 1 | |a Lestari, Trisasi |e verfasserin |4 aut | |
| 700 | 1 | |a Kal, Margaret |e verfasserin |4 aut | |
| 700 | 1 | |a Tsogt, Bazarragchaa |e verfasserin |4 aut | |
| 700 | 1 | |a Dorj, Gantsetseg |e verfasserin |4 aut | |
| 700 | 1 | |a Purev, Enkhtsetseg |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, Thu Anh |e verfasserin |4 aut | |
| 700 | 1 | |a Naidoo, Lenny |e verfasserin |4 aut | |
| 700 | 1 | |a Mvusi, Lindiwe |e verfasserin |4 aut | |
| 700 | 1 | |a Schaaf, Hendrik Simon |e verfasserin |4 aut | |
| 700 | 1 | |a Hesseling, Anneke C |e verfasserin |4 aut | |
| 700 | 1 | |a de Oliveira Rossoni, Andrea Maciel |e verfasserin |4 aut | |
| 700 | 1 | |a Carvalho, Anna Cristina Calçada |e verfasserin |4 aut | |
| 700 | 1 | |a Cardoso, Claudete Aparecida Araújo |e verfasserin |4 aut | |
| 700 | 1 | |a Sant'Anna, Clemax Couto |e verfasserin |4 aut | |
| 700 | 1 | |a Orti, Danielle Gomes Dell' |e verfasserin |4 aut | |
| 700 | 1 | |a Costa, Fernanda Dockhorn |e verfasserin |4 aut | |
| 700 | 1 | |a Vega, Liliana Romero |e verfasserin |4 aut | |
| 700 | 1 | |a Sant'Anna, Maria de Fátima Pombo |e verfasserin |4 aut | |
| 700 | 1 | |a Hoa, Nguyen Binh |e verfasserin |4 aut | |
| 700 | 1 | |a Phuc, Phan Huu |e verfasserin |4 aut | |
| 700 | 1 | |a Fiogbe, Attannon Arnauld |e verfasserin |4 aut | |
| 700 | 1 | |a Affolabi, Dissou |e verfasserin |4 aut | |
| 700 | 1 | |a Badoum, Gisèle |e verfasserin |4 aut | |
| 700 | 1 | |a Ouédraogo, Abdoul Risgou |e verfasserin |4 aut | |
| 700 | 1 | |a Saouadogo, Tandaogo |e verfasserin |4 aut | |
| 700 | 1 | |a Combary, Adjima |e verfasserin |4 aut | |
| 700 | 1 | |a Kuate Kuate, Albert |e verfasserin |4 aut | |
| 700 | 1 | |a Prudence, Bisso Ngono Annie |e verfasserin |4 aut | |
| 700 | 1 | |a Magassouba, Aboubakar Sidiki |e verfasserin |4 aut | |
| 700 | 1 | |a Bangoura, Adama Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Soumana, Alphazazi |e verfasserin |4 aut | |
| 700 | 1 | |a Hermana, Georges |e verfasserin |4 aut | |
| 700 | 1 | |a Gando, Hervé |e verfasserin |4 aut | |
| 700 | 1 | |a Fall, Nafissatou |e verfasserin |4 aut | |
| 700 | 1 | |a Gning, Barnabé |e verfasserin |4 aut | |
| 700 | 1 | |a Dogo, Mohammed Fall |e verfasserin |4 aut | |
| 700 | 1 | |a Mbitikon, Olivia |e verfasserin |4 aut | |
| 700 | 1 | |a Deffense, Manon |e verfasserin |4 aut | |
| 700 | 1 | |a Zimba, Kevin |e verfasserin |4 aut | |
| 700 | 1 | |a Chabala, Chishala |e verfasserin |4 aut | |
| 700 | 1 | |a Sekadde, Moorine Penninah |e verfasserin |4 aut | |
| 700 | 1 | |a Luzze, Henry |e verfasserin |4 aut | |
| 700 | 1 | |a Turyahabwe, Stavia |e verfasserin |4 aut | |
| 700 | 1 | |a Dongo, John Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Lopes, Constantino |e verfasserin |4 aut | |
| 700 | 1 | |a Dos Santos, Milena |e verfasserin |4 aut | |
| 700 | 1 | |a Francis, Joshua Reginald |e verfasserin |4 aut | |
| 700 | 1 | |a Arango-Loboguerrero, Magnolia |e verfasserin |4 aut | |
| 700 | 1 | |a Perez-Velez, Carlos M |e verfasserin |4 aut | |
| 700 | 1 | |a Koura, Kobto Ghislain |e verfasserin |4 aut | |
| 700 | 1 | |a Graham, Stephen M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pathogens (Basel, Switzerland) |d 2011 |g 11(2022), 2 vom: 01. Feb. |w (DE-627)NLM22512761X |x 2076-0817 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2022 |g number:2 |g day:01 |g month:02 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/pathogens11020196 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2022 |e 2 |b 01 |c 02 | ||